Esther C.W. Breij

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

Marije B. Overdijk, Sandra Verploegen, Marijn Bögels et al. · mAbs · 2015 · 491 citations · Full text

Homogeneity of active demyelinating lesions in established multiple sclerosis

Esther C.W. Breij, Bianca P. Brink, Rob Veerhuis et al. · Annals of Neurology · 2008 · 349 citations

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman et al. · Nature Medicine · 2018 · 215 citations

Melanoma Heterogeneity, Axl Antibody-drug Conjugate, Drug Targeting +11

An Antibody–Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors

Esther C.W. Breij, Bart E.C.G. de Goeij, Sandra Verploegen et al. · Cancer Research · 2013 · 214 citations · Full text

Tf Humab, Solid Tumors, Immunology +19

The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions

Bianca P. Brink, Robert Veerhuis, Esther C.W. Breij et al. · Journal of Neuropathology & Experimental Neurology · 2005 · 188 citations · Full text

Neurological Disorder, White Matter, Immunology +21